Nanjing, China · Founded 2010 · Privately Held (backing)
Developer of innovative drugs designed to treat cardiovascular and cerebrovascular, tumors, endocrine, and other areas of chronic diseases. Jiangsu Vcare is based in Nanjing, China and was founded in 2010. Its last reported valuation was $162 million in Feb 2021. It has raised $225 million.
Last reported valuation
$162.4M
Oct 2026
Priced at
—
Total raised
$225.4M
Last round
—
Team — not yet on record
No current team members for Jiangsu Vcare are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Jiangsu Vcare with a free account
·The complete investor list: 17 names
·Watch Jiangsu Vcare: the Monday email on marks, rounds and moves
